 Kentaro Yomogida
Concepts (418)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcription Factors | 14 | 2023 | 1528 | 1.410 |
Why?
| | Muscles | 2 | 2024 | 320 | 0.990 |
Why?
| | Testis | 27 | 2008 | 133 | 0.970 |
Why?
| | Spermatogenesis | 17 | 2013 | 52 | 0.910 |
Why?
| | Ice | 1 | 2024 | 16 | 0.900 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2023 | 12 | 0.890 |
Why?
| | T-Box Domain Proteins | 2 | 2021 | 92 | 0.790 |
Why?
| | Lymphocyte Subsets | 1 | 2021 | 79 | 0.760 |
Why?
| | Sertoli Cells | 7 | 2004 | 21 | 0.700 |
Why?
| | Perciformes | 1 | 2020 | 17 | 0.690 |
Why?
| | Immunity, Cellular | 1 | 2021 | 248 | 0.680 |
Why?
| | Cryopreservation | 1 | 2020 | 92 | 0.650 |
Why?
| | Immunity, Innate | 2 | 2021 | 720 | 0.630 |
Why?
| | Interleukin-17 | 2 | 2014 | 104 | 0.520 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2013 | 66 | 0.500 |
Why?
| | Mice | 46 | 2024 | 14872 | 0.500 |
Why?
| | DNA-Binding Proteins | 12 | 2008 | 1314 | 0.470 |
Why?
| | Superantigens | 1 | 2013 | 69 | 0.430 |
Why?
| | Th1 Cells | 1 | 2013 | 123 | 0.410 |
Why?
| | Magnetic Fields | 2 | 2024 | 22 | 0.400 |
Why?
| | Cell Polarity | 1 | 2013 | 131 | 0.400 |
Why?
| | Streptavidin | 1 | 2012 | 14 | 0.400 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 170 | 0.390 |
Why?
| | Freezing | 2 | 2024 | 84 | 0.390 |
Why?
| | Animals | 51 | 2024 | 31709 | 0.390 |
Why?
| | Arthritis, Experimental | 1 | 2013 | 130 | 0.380 |
Why?
| | Interferon-gamma | 3 | 2021 | 719 | 0.360 |
Why?
| | Interleukin-2 | 1 | 2012 | 413 | 0.360 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2013 | 339 | 0.350 |
Why?
| | Lymphocyte Activation | 1 | 2012 | 1037 | 0.300 |
Why?
| | Intestinal Mucosa | 2 | 2023 | 532 | 0.280 |
Why?
| | Spermatogonia | 7 | 2008 | 11 | 0.270 |
Why?
| | Mice, Inbred C57BL | 18 | 2023 | 4694 | 0.260 |
Why?
| | Nerve Growth Factors | 2 | 2003 | 71 | 0.260 |
Why?
| | Germ Cells | 7 | 2004 | 57 | 0.260 |
Why?
| | Gene Expression Regulation | 8 | 2021 | 2320 | 0.250 |
Why?
| | T-Lymphocytes | 1 | 2012 | 1737 | 0.230 |
Why?
| | CD8 Antigens | 1 | 2023 | 69 | 0.220 |
Why?
| | Crystallization | 1 | 2024 | 136 | 0.220 |
Why?
| | Interleukin-15 | 1 | 2023 | 74 | 0.220 |
Why?
| | RNA, Messenger | 20 | 2011 | 2553 | 0.220 |
Why?
| | Mice, Knockout | 7 | 2023 | 2570 | 0.220 |
Why?
| | Base Sequence | 22 | 2006 | 2114 | 0.210 |
Why?
| | Membrane Proteins | 3 | 2021 | 1019 | 0.210 |
Why?
| | Haploidy | 8 | 2003 | 21 | 0.210 |
Why?
| | Zinc Fingers | 4 | 2000 | 43 | 0.200 |
Why?
| | Spermatozoa | 7 | 2006 | 84 | 0.200 |
Why?
| | Neuroglia | 1 | 2003 | 150 | 0.200 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 39 | 0.200 |
Why?
| | RNA, Small Cytoplasmic | 1 | 2021 | 6 | 0.200 |
Why?
| | Cell Nucleus | 7 | 2005 | 554 | 0.190 |
Why?
| | Granzymes | 1 | 2021 | 40 | 0.190 |
Why?
| | Spermatids | 7 | 2013 | 18 | 0.190 |
Why?
| | Liver | 3 | 2021 | 1637 | 0.180 |
Why?
| | Molecular Sequence Data | 20 | 2005 | 2785 | 0.170 |
Why?
| | Receptors, Cell Surface | 1 | 2022 | 355 | 0.170 |
Why?
| | Gene Deletion | 1 | 2021 | 356 | 0.170 |
Why?
| | Eosinophils | 1 | 2022 | 278 | 0.170 |
Why?
| | Transcription, Genetic | 13 | 2008 | 1313 | 0.170 |
Why?
| | DNA, Complementary | 8 | 2005 | 256 | 0.170 |
Why?
| | Palatine Tonsil | 1 | 2019 | 32 | 0.160 |
Why?
| | Antigens, CD | 1 | 2021 | 442 | 0.160 |
Why?
| | Cell Differentiation | 12 | 2019 | 1701 | 0.160 |
Why?
| | Gene Expression | 6 | 2003 | 1421 | 0.160 |
Why?
| | Myxoma | 1 | 2018 | 11 | 0.160 |
Why?
| | Heart Neoplasms | 1 | 2018 | 49 | 0.150 |
Why?
| | Heart Atria | 1 | 2018 | 107 | 0.150 |
Why?
| | Cell Line | 9 | 2014 | 2637 | 0.150 |
Why?
| | Transfection | 8 | 2014 | 866 | 0.150 |
Why?
| | 5-Aminolevulinate Synthetase | 2 | 1997 | 2 | 0.140 |
Why?
| | Lymphocytes | 1 | 2019 | 330 | 0.140 |
Why?
| | Interleukins | 1 | 2019 | 236 | 0.140 |
Why?
| | Mice, Mutant Strains | 3 | 2003 | 271 | 0.140 |
Why?
| | Amino Acid Sequence | 15 | 2005 | 1982 | 0.130 |
Why?
| | Stem Cells | 4 | 2002 | 546 | 0.130 |
Why?
| | Proto-Oncogene Proteins | 3 | 2008 | 608 | 0.130 |
Why?
| | Cloning, Molecular | 9 | 2005 | 522 | 0.130 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 2006 | 127 | 0.130 |
Why?
| | Green Fluorescent Proteins | 8 | 2005 | 371 | 0.120 |
Why?
| | Cell Proliferation | 2 | 2013 | 2187 | 0.120 |
Why?
| | Blotting, Northern | 11 | 2003 | 193 | 0.120 |
Why?
| | Immunohistochemistry | 10 | 2013 | 1629 | 0.120 |
Why?
| | Male | 43 | 2013 | 55609 | 0.120 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2014 | 11 | 0.120 |
Why?
| | Recombinant Fusion Proteins | 4 | 2013 | 616 | 0.120 |
Why?
| | Proteins | 4 | 2005 | 908 | 0.120 |
Why?
| | Th17 Cells | 1 | 2014 | 58 | 0.110 |
Why?
| | CD4 Antigens | 1 | 2014 | 123 | 0.110 |
Why?
| | Exons | 9 | 2011 | 302 | 0.110 |
Why?
| | Biomarkers | 3 | 2021 | 3408 | 0.110 |
Why?
| | Cell Division | 5 | 2003 | 758 | 0.110 |
Why?
| | Acrosome | 1 | 2013 | 4 | 0.110 |
Why?
| | Monomeric Clathrin Assembly Proteins | 1 | 2013 | 5 | 0.110 |
Why?
| | trans-Golgi Network | 1 | 2013 | 11 | 0.110 |
Why?
| | Zymosan | 1 | 2013 | 64 | 0.110 |
Why?
| | Carbolines | 1 | 2013 | 27 | 0.110 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2013 | 36 | 0.100 |
Why?
| | Protein Transport | 2 | 2013 | 395 | 0.100 |
Why?
| | Culture Media | 1 | 2013 | 155 | 0.100 |
Why?
| | Cell Membrane Permeability | 1 | 2013 | 83 | 0.100 |
Why?
| | Quality Improvement | 1 | 2020 | 950 | 0.100 |
Why?
| | Genes, Bacterial | 1 | 1993 | 157 | 0.100 |
Why?
| | Microcirculation | 1 | 2013 | 135 | 0.100 |
Why?
| | Luminescent Proteins | 6 | 2003 | 166 | 0.100 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 535 | 0.100 |
Why?
| | Promoter Regions, Genetic | 7 | 2011 | 1131 | 0.100 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2013 | 309 | 0.090 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2013 | 352 | 0.090 |
Why?
| | Nuclear Proteins | 3 | 2003 | 591 | 0.090 |
Why?
| | Seminiferous Tubules | 5 | 2008 | 10 | 0.090 |
Why?
| | Spleen | 1 | 2013 | 487 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 314 | 0.090 |
Why?
| | Meiosis | 2 | 2003 | 59 | 0.090 |
Why?
| | Autophagy | 1 | 2013 | 235 | 0.090 |
Why?
| | Histones | 3 | 2006 | 535 | 0.090 |
Why?
| | Gene Library | 8 | 2003 | 114 | 0.090 |
Why?
| | Lymph Nodes | 1 | 2013 | 419 | 0.090 |
Why?
| | In Situ Hybridization | 8 | 2004 | 292 | 0.090 |
Why?
| | Inflammation Mediators | 1 | 2013 | 477 | 0.090 |
Why?
| | Heat-Shock Proteins | 3 | 2006 | 113 | 0.090 |
Why?
| | Infertility, Male | 3 | 2013 | 59 | 0.080 |
Why?
| | Estrogen Receptor alpha | 1 | 2011 | 121 | 0.080 |
Why?
| | Burns | 1 | 2013 | 237 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 5 | 2008 | 801 | 0.080 |
Why?
| | Cell Membrane | 1 | 2013 | 680 | 0.080 |
Why?
| | Testicular Neoplasms | 2 | 2003 | 96 | 0.080 |
Why?
| | Humans | 23 | 2019 | 114709 | 0.080 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 2 | 2006 | 39 | 0.080 |
Why?
| | Genes, Reporter | 6 | 2013 | 257 | 0.080 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2014 | 959 | 0.080 |
Why?
| | Flow Cytometry | 1 | 2012 | 1083 | 0.080 |
Why?
| | Cytoplasm | 3 | 2005 | 255 | 0.080 |
Why?
| | Blotting, Western | 6 | 2013 | 1147 | 0.070 |
Why?
| | Protein Biosynthesis | 5 | 2003 | 387 | 0.070 |
Why?
| | Peptides | 1 | 2013 | 848 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2019 | 3886 | 0.070 |
Why?
| | Alternative Splicing | 3 | 2011 | 187 | 0.070 |
Why?
| | Mouth Neoplasms | 1 | 2008 | 70 | 0.070 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2008 | 119 | 0.070 |
Why?
| | Endoplasmic Reticulum | 2 | 2006 | 234 | 0.070 |
Why?
| | Response Elements | 2 | 2005 | 82 | 0.070 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 2 | 2003 | 16 | 0.070 |
Why?
| | Cyclic AMP Response Element Modulator | 1 | 2006 | 2 | 0.070 |
Why?
| | Receptors, Androgen | 2 | 2005 | 131 | 0.070 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2006 | 88 | 0.060 |
Why?
| | Recombinant Proteins | 3 | 2005 | 1230 | 0.060 |
Why?
| | Sperm Tail | 2 | 2002 | 5 | 0.060 |
Why?
| | Nucleocytoplasmic Transport Proteins | 1 | 2005 | 6 | 0.060 |
Why?
| | Glycoside Hydrolases | 1 | 2005 | 30 | 0.060 |
Why?
| | Mice, Transgenic | 7 | 2005 | 1950 | 0.060 |
Why?
| | Erythroid-Specific DNA-Binding Factors | 4 | 2003 | 18 | 0.060 |
Why?
| | Gene Targeting | 3 | 2013 | 75 | 0.060 |
Why?
| | GATA1 Transcription Factor | 4 | 2003 | 13 | 0.060 |
Why?
| | Multigene Family | 1 | 2005 | 190 | 0.060 |
Why?
| | Genes | 2 | 2003 | 223 | 0.060 |
Why?
| | Follicle Stimulating Hormone | 2 | 2002 | 216 | 0.060 |
Why?
| | GATA4 Transcription Factor | 1 | 2004 | 17 | 0.060 |
Why?
| | Mice, Inbred ICR | 1 | 2004 | 109 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1473 | 0.060 |
Why?
| | Olfactory Receptor Neurons | 1 | 2004 | 67 | 0.060 |
Why?
| | Female | 14 | 2018 | 59523 | 0.060 |
Why?
| | Mitochondrial ADP, ATP Translocases | 1 | 2003 | 1 | 0.050 |
Why?
| | Electroporation | 1 | 2003 | 31 | 0.050 |
Why?
| | Up-Regulation | 2 | 2004 | 808 | 0.050 |
Why?
| | Phylogeny | 3 | 2005 | 789 | 0.050 |
Why?
| | Stem Cell Factor | 2 | 2000 | 14 | 0.050 |
Why?
| | DNA Damage | 1 | 2005 | 351 | 0.050 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 577 | 0.050 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2003 | 54 | 0.050 |
Why?
| | Genetic Engineering | 1 | 2003 | 80 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1143 | 0.050 |
Why?
| | HeLa Cells | 4 | 2006 | 562 | 0.050 |
Why?
| | Chromosome Mapping | 4 | 2011 | 487 | 0.050 |
Why?
| | Procollagen | 1 | 2002 | 19 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 923 | 0.050 |
Why?
| | Prostatic Intraepithelial Neoplasia | 1 | 2002 | 12 | 0.050 |
Why?
| | Spermatocytes | 2 | 2005 | 6 | 0.050 |
Why?
| | Teratoma | 1 | 2003 | 92 | 0.050 |
Why?
| | RNA-Binding Proteins | 1 | 2005 | 345 | 0.050 |
Why?
| | Molecular Chaperones | 2 | 2006 | 157 | 0.050 |
Why?
| | Tissue Distribution | 4 | 2004 | 286 | 0.050 |
Why?
| | Leukocyte Count | 1 | 2022 | 293 | 0.050 |
Why?
| | DNA | 5 | 2013 | 1352 | 0.050 |
Why?
| | Gene Expression Profiling | 2 | 2005 | 1518 | 0.050 |
Why?
| | Immunomodulation | 1 | 2022 | 84 | 0.050 |
Why?
| | Intestine, Small | 1 | 2022 | 122 | 0.050 |
Why?
| | Leydig Cells | 2 | 1998 | 11 | 0.050 |
Why?
| | Coenzyme A-Transferases | 1 | 2000 | 1 | 0.050 |
Why?
| | Tumor Suppressor Proteins | 1 | 2003 | 282 | 0.050 |
Why?
| | Ovary | 1 | 2002 | 191 | 0.050 |
Why?
| | Actins | 1 | 2003 | 381 | 0.050 |
Why?
| | Rats | 7 | 1999 | 4958 | 0.040 |
Why?
| | Androgen-Binding Protein | 1 | 2000 | 1 | 0.040 |
Why?
| | Ligands | 1 | 2022 | 562 | 0.040 |
Why?
| | Eosinophilia | 1 | 2022 | 186 | 0.040 |
Why?
| | Collagen | 1 | 2002 | 415 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2000 | 63 | 0.040 |
Why?
| | Testicular Hormones | 1 | 1999 | 9 | 0.040 |
Why?
| | Binding Sites | 4 | 2006 | 1168 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-ets | 3 | 2008 | 51 | 0.040 |
Why?
| | Protein Isoforms | 3 | 2011 | 338 | 0.040 |
Why?
| | Chromatin | 1 | 2003 | 428 | 0.040 |
Why?
| | Ikaros Transcription Factor | 1 | 2019 | 18 | 0.040 |
Why?
| | Purpura | 1 | 2018 | 13 | 0.040 |
Why?
| | Prostate | 1 | 2000 | 156 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 4 | 2000 | 353 | 0.040 |
Why?
| | Sequence Analysis, DNA | 4 | 2005 | 723 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 70 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2002 | 530 | 0.040 |
Why?
| | Exanthema | 1 | 2018 | 74 | 0.040 |
Why?
| | Testosterone | 1 | 2001 | 343 | 0.040 |
Why?
| | Food Hypersensitivity | 1 | 2022 | 251 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 1999 | 164 | 0.040 |
Why?
| | Luciferases | 3 | 2005 | 142 | 0.040 |
Why?
| | Anemia, Sideroblastic | 1 | 1997 | 3 | 0.040 |
Why?
| | Transferrin | 1 | 1997 | 39 | 0.040 |
Why?
| | Cell Lineage | 1 | 1999 | 309 | 0.040 |
Why?
| | X Chromosome | 1 | 1997 | 47 | 0.040 |
Why?
| | Endopeptidases | 1 | 1997 | 71 | 0.040 |
Why?
| | Pyridoxine | 1 | 1997 | 28 | 0.040 |
Why?
| | Erythropoiesis | 1 | 1997 | 33 | 0.040 |
Why?
| | Fever | 1 | 2018 | 280 | 0.040 |
Why?
| | Recombination, Genetic | 1 | 1998 | 176 | 0.030 |
Why?
| | Fatigue | 1 | 2018 | 294 | 0.030 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1997 | 81 | 0.030 |
Why?
| | Nucleic Acid Hybridization | 2 | 1997 | 187 | 0.030 |
Why?
| | Introns | 4 | 1999 | 227 | 0.030 |
Why?
| | Phosphoprotein Phosphatases | 1 | 1996 | 64 | 0.030 |
Why?
| | Point Mutation | 1 | 1997 | 216 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 1999 | 351 | 0.030 |
Why?
| | Echocardiography | 1 | 2018 | 553 | 0.030 |
Why?
| | Prostatic Neoplasms | 1 | 2002 | 921 | 0.030 |
Why?
| | Crosses, Genetic | 2 | 2008 | 139 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1342 | 0.030 |
Why?
| | Microscopy, Fluorescence | 3 | 2000 | 396 | 0.030 |
Why?
| | Sperm Motility | 2 | 2004 | 26 | 0.030 |
Why?
| | Clathrin-Coated Vesicles | 1 | 2013 | 3 | 0.030 |
Why?
| | Syntaxin 1 | 1 | 2013 | 14 | 0.030 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1996 | 333 | 0.030 |
Why?
| | Clathrin | 1 | 2013 | 27 | 0.030 |
Why?
| | Aging | 4 | 2008 | 1618 | 0.030 |
Why?
| | Tadalafil | 1 | 2013 | 7 | 0.030 |
Why?
| | Chemotactic Factors | 1 | 1993 | 50 | 0.030 |
Why?
| | Dimerization | 2 | 2006 | 176 | 0.030 |
Why?
| | TATA Box | 1 | 1993 | 22 | 0.030 |
Why?
| | Chemokines, CXC | 1 | 1993 | 60 | 0.030 |
Why?
| | Survival | 1 | 2013 | 37 | 0.030 |
Why?
| | Biological Transport | 2 | 2005 | 374 | 0.030 |
Why?
| | Pain | 1 | 2018 | 705 | 0.030 |
Why?
| | Growth Substances | 1 | 1993 | 138 | 0.030 |
Why?
| | Cricetinae | 2 | 2005 | 253 | 0.030 |
Why?
| | In Vitro Techniques | 2 | 2006 | 1016 | 0.030 |
Why?
| | Rats, Wistar | 1 | 1993 | 368 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2013 | 304 | 0.020 |
Why?
| | Apoptosis | 3 | 2006 | 2363 | 0.020 |
Why?
| | Anemia | 1 | 1993 | 143 | 0.020 |
Why?
| | Species Specificity | 2 | 2005 | 542 | 0.020 |
Why?
| | Random Amplified Polymorphic DNA Technique | 1 | 2011 | 2 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 2013 | 424 | 0.020 |
Why?
| | Wound Healing | 1 | 2013 | 258 | 0.020 |
Why?
| | Protein Structure, Tertiary | 2 | 2005 | 796 | 0.020 |
Why?
| | Blotting, Southern | 2 | 2001 | 68 | 0.020 |
Why?
| | Organ Specificity | 2 | 2002 | 268 | 0.020 |
Why?
| | Gestational Age | 1 | 1993 | 760 | 0.020 |
Why?
| | Cell Fractionation | 2 | 2000 | 51 | 0.020 |
Why?
| | Cell Cycle | 2 | 2005 | 542 | 0.020 |
Why?
| | Mice, Inbred Strains | 2 | 2001 | 396 | 0.020 |
Why?
| | Transcriptional Activation | 2 | 2005 | 337 | 0.020 |
Why?
| | DNA Primers | 2 | 2003 | 510 | 0.020 |
Why?
| | Mice, Inbred BALB C | 2 | 2003 | 1144 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2011 | 591 | 0.020 |
Why?
| | Cell Movement | 2 | 2004 | 869 | 0.020 |
Why?
| | Heterozygote | 1 | 2008 | 251 | 0.020 |
Why?
| | Animals, Newborn | 2 | 2003 | 778 | 0.020 |
Why?
| | Time Factors | 3 | 2004 | 6116 | 0.020 |
Why?
| | Organ Size | 1 | 2008 | 436 | 0.020 |
Why?
| | Fertility | 1 | 2008 | 130 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3053 | 0.020 |
Why?
| | Protein Binding | 2 | 2005 | 1890 | 0.020 |
Why?
| | Neutrophils | 1 | 1993 | 1176 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2001 | 388 | 0.020 |
Why?
| | Rats, Inbred F344 | 2 | 1998 | 241 | 0.020 |
Why?
| | Models, Genetic | 2 | 2000 | 562 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2008 | 442 | 0.020 |
Why?
| | Histone Chaperones | 1 | 2006 | 13 | 0.020 |
Why?
| | Microscopy, Electron | 1 | 2006 | 410 | 0.020 |
Why?
| | Bone Marrow | 2 | 1997 | 244 | 0.020 |
Why?
| | Child, Preschool | 1 | 2019 | 9119 | 0.020 |
Why?
| | Cycloheximide | 1 | 2005 | 54 | 0.020 |
Why?
| | Leucine Zippers | 1 | 2005 | 16 | 0.020 |
Why?
| | Neurospora crassa | 1 | 2005 | 16 | 0.020 |
Why?
| | Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2005 | 13 | 0.020 |
Why?
| | Hydroxyurea | 1 | 2005 | 30 | 0.020 |
Why?
| | Gene Components | 1 | 2005 | 5 | 0.020 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 2005 | 38 | 0.020 |
Why?
| | Caspases | 1 | 2006 | 245 | 0.020 |
Why?
| | Cricetulus | 1 | 2005 | 97 | 0.020 |
Why?
| | Half-Life | 1 | 2005 | 141 | 0.020 |
Why?
| | Histidine | 1 | 2005 | 57 | 0.020 |
Why?
| | Metribolone | 1 | 2005 | 5 | 0.020 |
Why?
| | Nuclear Pore Complex Proteins | 1 | 2005 | 31 | 0.020 |
Why?
| | Mitochondria | 2 | 2003 | 747 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2005 | 72 | 0.020 |
Why?
| | HSP40 Heat-Shock Proteins | 1 | 2005 | 21 | 0.020 |
Why?
| | Glycosylation | 1 | 2005 | 130 | 0.020 |
Why?
| | Adherens Junctions | 1 | 2005 | 26 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2005 | 151 | 0.010 |
Why?
| | Flagella | 1 | 2004 | 18 | 0.010 |
Why?
| | Sperm-Ovum Interactions | 1 | 2004 | 12 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2005 | 167 | 0.010 |
Why?
| | Fertilization | 1 | 2004 | 41 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2005 | 323 | 0.010 |
Why?
| | Receptors, Odorant | 1 | 2004 | 35 | 0.010 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2005 | 139 | 0.010 |
Why?
| | Chemotaxis | 1 | 2004 | 130 | 0.010 |
Why?
| | DNA Replication | 1 | 2005 | 202 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2013 | 3535 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2005 | 289 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2004 | 227 | 0.010 |
Why?
| | Transcription Initiation Site | 1 | 2003 | 40 | 0.010 |
Why?
| | Ornithine Carbamoyltransferase | 1 | 2003 | 2 | 0.010 |
Why?
| | Protamines | 1 | 2003 | 5 | 0.010 |
Why?
| | Cell Culture Techniques | 1 | 2005 | 343 | 0.010 |
Why?
| | Models, Chemical | 1 | 2004 | 248 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 1 | 2005 | 399 | 0.010 |
Why?
| | HSP47 Heat-Shock Proteins | 1 | 2002 | 4 | 0.010 |
Why?
| | Ultraviolet Rays | 1 | 2005 | 363 | 0.010 |
Why?
| | Seminal Plasma Proteins | 1 | 2002 | 10 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 2003 | 228 | 0.010 |
Why?
| | Restriction Mapping | 1 | 2002 | 77 | 0.010 |
Why?
| | Genome | 1 | 2005 | 271 | 0.010 |
Why?
| | Cytoskeletal Proteins | 1 | 2003 | 145 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 2002 | 78 | 0.010 |
Why?
| | Base Pairing | 1 | 2002 | 59 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2003 | 213 | 0.010 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2002 | 16 | 0.010 |
Why?
| | Enhancer Elements, Genetic | 1 | 2003 | 151 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2006 | 551 | 0.010 |
Why?
| | Isoenzymes | 1 | 2003 | 283 | 0.010 |
Why?
| | Bromodeoxyuridine | 1 | 2002 | 72 | 0.010 |
Why?
| | COS Cells | 1 | 2002 | 175 | 0.010 |
Why?
| | PTEN Phosphohydrolase | 1 | 2003 | 140 | 0.010 |
Why?
| | Flutamide | 1 | 2001 | 5 | 0.010 |
Why?
| | Prostatic Hyperplasia | 1 | 2002 | 38 | 0.010 |
Why?
| | Escherichia coli | 1 | 2005 | 720 | 0.010 |
Why?
| | Mice, Nude | 1 | 2003 | 630 | 0.010 |
Why?
| | Androgen Receptor Antagonists | 1 | 2001 | 30 | 0.010 |
Why?
| | Dipeptides | 1 | 2001 | 48 | 0.010 |
Why?
| | Pregnancy | 1 | 1993 | 5520 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2008 | 2711 | 0.010 |
Why?
| | Signal Transduction | 2 | 2005 | 4516 | 0.010 |
Why?
| | Fanconi Anemia Complementation Group Proteins | 1 | 2000 | 6 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1569 | 0.010 |
Why?
| | Precipitin Tests | 1 | 2000 | 88 | 0.010 |
Why?
| | Androgen Antagonists | 1 | 2001 | 69 | 0.010 |
Why?
| | Luteinizing Hormone | 1 | 2001 | 169 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 17855 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2000 | 152 | 0.010 |
Why?
| | Pancreas | 1 | 2003 | 276 | 0.010 |
Why?
| | Stromal Cells | 1 | 2001 | 97 | 0.010 |
Why?
| | Mutation | 2 | 2002 | 3346 | 0.010 |
Why?
| | Sequence Homology | 1 | 2000 | 39 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2004 | 1842 | 0.010 |
Why?
| | Basement Membrane | 1 | 2000 | 30 | 0.010 |
Why?
| | Phospholipid Transfer Proteins | 1 | 2000 | 11 | 0.010 |
Why?
| | Ornithine Decarboxylase Inhibitors | 1 | 2000 | 3 | 0.010 |
Why?
| | Ornithine Decarboxylase | 1 | 2000 | 9 | 0.010 |
Why?
| | Child | 1 | 2019 | 18422 | 0.010 |
Why?
| | Frameshifting, Ribosomal | 1 | 2000 | 6 | 0.010 |
Why?
| | Polyamines | 1 | 2000 | 35 | 0.010 |
Why?
| | CHO Cells | 1 | 2000 | 138 | 0.010 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2001 | 188 | 0.010 |
Why?
| | CapZ Actin Capping Protein | 1 | 1999 | 2 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2003 | 666 | 0.010 |
Why?
| | Plasmids | 1 | 2000 | 343 | 0.010 |
Why?
| | Open Reading Frames | 1 | 2000 | 117 | 0.010 |
Why?
| | Gonads | 1 | 1999 | 21 | 0.010 |
Why?
| | Inbreeding | 1 | 1999 | 16 | 0.010 |
Why?
| | CpG Islands | 1 | 1999 | 118 | 0.010 |
Why?
| | Stem Cell Transplantation | 1 | 2000 | 149 | 0.010 |
Why?
| | Calcium | 1 | 2004 | 1108 | 0.010 |
Why?
| | Kidney | 1 | 2005 | 1188 | 0.010 |
Why?
| | Fibroblasts | 1 | 2003 | 838 | 0.010 |
Why?
| | Selenoprotein P | 1 | 1998 | 3 | 0.010 |
Why?
| | Rabbits | 1 | 1999 | 733 | 0.010 |
Why?
| | Mesylates | 1 | 1998 | 8 | 0.010 |
Why?
| | Selenoproteins | 1 | 1998 | 8 | 0.010 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 1 | 1997 | 9 | 0.010 |
Why?
| | Receptors, LH | 1 | 1997 | 9 | 0.010 |
Why?
| | Cathepsin L | 1 | 1997 | 9 | 0.010 |
Why?
| | Clusterin | 1 | 1997 | 10 | 0.010 |
Why?
| | Drosophila melanogaster | 1 | 1999 | 191 | 0.010 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2000 | 308 | 0.010 |
Why?
| | Cathepsins | 1 | 1997 | 22 | 0.010 |
Why?
| | Erythroid Precursor Cells | 1 | 1997 | 4 | 0.010 |
Why?
| | Yolk Sac | 1 | 1997 | 5 | 0.010 |
Why?
| | Cysteine Endopeptidases | 1 | 1997 | 60 | 0.010 |
Why?
| | Aspartic Acid | 1 | 1997 | 77 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1997 | 94 | 0.010 |
Why?
| | Phenotype | 1 | 2005 | 2797 | 0.010 |
Why?
| | Valine | 1 | 1997 | 72 | 0.010 |
Why?
| | Protein Phosphatase 2C | 1 | 1996 | 14 | 0.010 |
Why?
| | Protein Phosphatase 2 | 1 | 1996 | 30 | 0.010 |
Why?
| | Genetic Markers | 1 | 1997 | 320 | 0.010 |
Why?
| | Conserved Sequence | 1 | 1997 | 218 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2000 | 695 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1996 | 352 | 0.010 |
Why?
| | Glycoproteins | 1 | 1997 | 304 | 0.010 |
Why?
| | Models, Biological | 1 | 2002 | 1621 | 0.010 |
Why?
| | RNA | 1 | 2000 | 809 | 0.010 |
Why?
| | Kinetics | 1 | 1998 | 1551 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2000 | 951 | 0.010 |
Why?
| | Antioxidants | 1 | 1998 | 530 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 1997 | 1167 | 0.010 |
Why?
| | Chemokine CXCL1 | 1 | 1993 | 68 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 1997 | 2765 | 0.010 |
Why?
| | Aged | 1 | 2002 | 19074 | 0.000 |
Why?
| | Middle Aged | 1 | 2002 | 26738 | 0.000 |
Why?
|
|
Yomogida's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|